These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29025829)

  • 1. Is an opportunistic primary care-based intervention for non-responders to bowel screening feasible and acceptable? A mixed-methods feasibility study in Scotland.
    Calanzani N; Cavers D; Vojt G; Orbell S; Steele RJC; Brownlee L; Smith S; Patnick J; Weller D; Campbell C
    BMJ Open; 2017 Oct; 7(10):e016307. PubMed ID: 29025829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an evidence-based brief 'talking' intervention for non-responders to bowel screening for use in primary care: stakeholder interviews.
    Cavers D; Calanzani N; Orbell S; Vojt G; Steele RJC; Brownlee L; Smith S; Patnick J; Weller D; Campbell C
    BMC Fam Pract; 2018 Jun; 19(1):105. PubMed ID: 29960599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipated regret to increase uptake of colorectal cancer screening in Scotland (ARTICS): study protocol for a randomised controlled trial.
    O'Carroll RE; Steele RJ; Libby G; Brownlee L; Chambers JA
    BMC Public Health; 2013 Sep; 13():849. PubMed ID: 24041309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative evaluation of strategies to increase colorectal cancer screening uptake.
    Tinmouth J; Ritvo P; McGregor SE; Claus D; Pasut G; Myers RE; Guglietti C; Paszat LF; Hilsden RJ; Rabeneck L
    Can Fam Physician; 2011 Jan; 57(1):e7-15. PubMed ID: 21322288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.
    Sewitch MJ; Jiang M; Grad R; Yaffe M; Pavilanis A; Joseph L; Barkun AN; Roper M
    Can Fam Physician; 2013 Dec; 59(12):e550-7. PubMed ID: 24336560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of opportunistic screening for occult gastrointestinal blood loss.
    Hobbs FD; Cherry RC; Fielding JW; Pike L; Holder R
    BMJ; 1992 Feb; 304(6825):483-6. PubMed ID: 1547423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Quyn AJ; Fraser CG; Rodger J; Digan A; Anderson AS; Steele RJC
    Br J Surg; 2018 Apr; 105(5):529-534. PubMed ID: 29465743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance.
    Ore L; Hagoel L; Lavi I; Rennert G
    Eur J Cancer Prev; 2001 Jun; 10(3):251-6. PubMed ID: 11432712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates.
    Potter MB; Phengrasamy L; Hudes ES; McPhee SJ; Walsh JM
    Ann Fam Med; 2009; 7(1):17-23. PubMed ID: 19139445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
    Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
    Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study.
    King C; Llewellyn C; Shahmanesh M; Abraham C; Bailey J; Burns F; Clark L; Copas A; Howarth A; Hughes G; Mercer C; Miners A; Pollard A; Richardson D; Rodger A; Roy A; Gilson R
    Health Technol Assess; 2019 Mar; 23(12):1-122. PubMed ID: 30916641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General practice perspectives on a bowel cancer screening quality improvement intervention using the Consolidated Framework for Implementation Research.
    Holden CA; Turnbull D; Frank OR; Olver I
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery: the PRE-OP BIRDS feasibility RCT.
    Snowden C; Lynch E; Avery L; Haighton C; Howel D; Mamasoula V; Gilvarry E; McColl E; Prentis J; Gerrand C; Steel A; Goudie N; Howe N; Kaner E
    Health Technol Assess; 2020 Mar; 24(12):1-176. PubMed ID: 32131964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
    Salimzadeh H; Bishehsari F; Sauvaget C; Amani M; Hamzehloo G; Nikfarjam A; Merat S; Delavari A; Malekzadeh R
    Arch Iran Med; 2017 Dec; 20(12):726-733. PubMed ID: 29664311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.